ESMO22: Glenn Hanna, MD | Dana-Farber Cancer Institute

Case Study: Identifying Molecular Residual Disease - Dr. Glenn HannaПодробнее

ESMO22: Toni Choueiri, MD | Dana-Farber Cancer InstituteПодробнее

Young Patients with Multiple Myeloma and Complications | Shonali Midha, MD | ESMO22 PennsylvaniaПодробнее

ESMO22: Ben Schlechter, MD | Dana-Farber Cancer InstituteПодробнее

ESMO22: Breast cancer research by Sara Tolaney, MD | Dana-Farber Cancer InstituteПодробнее

ESMO22: Breast cancer research by Sara Tolaney, MD (TROPiCS) | Dana-Farber Cancer InstituteПодробнее

ESMO22: Catherine Marinac, PhD | Dana-Farber Cancer InstituteПодробнее